Evidence map›Paper›PMID 29475564›Full record

ReviewTrends in neurosciences2018

Long Road to Ruin: Noradrenergic Dysfunction in Neurodegenerative Disease.

David Weinshenker

Abstract readReview
In one paragraph

Review in Trends in neurosciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 202 papers.

0numbers the graph read from it
0cells of the map it votes in
202citing papers in PubMed
15.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

202 citing papers in PubMed, 328 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Cortical synchrony is reduced in Alzheimer's disease and relates to arousal state.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  19. Review
  20. Article

142 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

David WeinshenkerDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: dweinsh@emory.edu.
Emory University · US

Funding

Norepinephrine-dopamine interactions underlying arousalR01NS102306 · NINDS · EMORY UNIVERSITY · PI MITRANO, DARLENE A, WEINSHENKER, DAVID · 2017 to 2021
$1.8M
Consequences of Locus Coeruleus Activation in a Rat Model of Alzheimer's DiseaseRF1AG047667 · NIA · EMORY UNIVERSITY · PI WEINSHENKER, DAVID · 2014 to 2014
$1.7M
NIA NIH HHS RF1 AG047667NINDS NIH HHS R01 NS102306
6 · The paper itself

Abstract

It has been known for decades that degeneration of the locus coeruleus (LC), the major noradrenergic nucleus in the brain, occurs in both Alzheimer's disease (AD) and Parkinson's disease (PD), but it was given scant attention. It is now recognized that hyperphosphorylated tau in the LC is the first detectable AD-like neuropathology in the human brain, α-synuclein inclusions in the LC represent an early step in PD, and experimental LC lesions exacerbate neuropathology and cognitive/behavioral deficits in animal models. The purpose of this review is to consider the causes and consequences of LC pathology, dysfunction, and degeneration, as well as their implications for early detection and treatment.

Indexed as

alpha-SynucleinAlzheimer DiseaseAnimalsCognitive DysfunctionHumansLocus CoeruleusNeuronsParkinson Diseasealpha-Synucleinalpha-synucleinAlzheimer’s diseaselocus coeruleusParkinson’s diseasetau

Identifiers

PMID29475564
PMCPMC5878728
OpenAlexW2788770082

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.